Prof Tao WangMD, PhD, SFHEA

Overview

Tao Wang leads a research group investigating the molecular basis of cardiovascular diseases, focusing on genetic vascular conditions and the Notch signalling in cardiovascular system. She has expertise in establishing and characterising the patient-specific induced pluripotent stem cell (iPSC) models and identifying therapeutic targets. Her group also conducts research on Nano-medicine. Her current work focuses on using iPSCs to model genetic small vessel diseases and explore how vascular factors contribute to neurodegeneration by looking into the neurovascular interactions. She supervises a number of PhD students and Master degree students. She is the Director of an international postgraduate Programme on Clinical Genetics and Genetic Counselling. She pear reviews grant applications for a number of funding bodies and manuscripts for international journals. She sits on the Managing Editorial Board of Frontiers in Bioscience and is the Managing Editor of the FBS special issue Signalling Pathways in Cardiovascular Function and Diseases. She is also sits on Editorial Boards for a number of other international journals including American Journal of Clinical and Experimental Medicine, Signal Transduction Insights, Recent Patents on CNS Drug Discovery, and Journal of Nanoparticles & Nanotechnology, and so on.

Biography

2018 - Now       Professor of Molecular Medicine

2014 – 2018      Senior Lecturer, The University of Manchester

2003 – 2013      Lecturer/Research Fellow, The University of Manchester

2001 – 2003      Postdoc, Department of Medical Genetics, University of Cambridge

1992 - 2001       Postdoc, Department of Medicine, University of Cambridge

1986 – 1992      Physician Cardiologists, the 3rd Hospital of Peking University

1988 – 2001      PhD, the 3rd Hospital of Peking University Health Science Centre

1981 – 1986      Medical student, China Medical University    

Qualifications

MD, PhD, SFHEA

Memberships of committees and professional bodies

• Member of British Society for Cardiovascular Research
• Member of British Atherosclerosis Society
• Member of the International Society for Stem Cell Research
• Managing Editorial Board, Frontiers in Bioscience (FBS)
• Managing Editor, Signalling Pathways in Cardiovascular Function and Diseases (FBS special issue)
• Member of Editorial Board, American Journal of Clinical and Experimental Medicine
• Member of Editorial Board, Signal Transduction Insights (an online journal)
• Member of Editorial Board (previous), Recent Patents on CNS Drug Discovery
• Overseas Editor for Chinese Journal of Biochemistry and Molecular Biology (CJBMB)
• Overseas Editor for Chinese Journal of Cardiovascular Review